Von Eschenbach Replaces Crawford as FDA Chief
Filed in archive Other Biotechnology News on September 28, 2005
Following the resignation of FDA Commissioner Lester M. Crawford effective September 23, President Bush appoints Dr. Andrew C. von Eschenbach, head of the National Cancer Institute as replacement. The new chief promises to look into ways of improving FDA operations, i.e. speed up timelines without sacrificing patient safety.
Read more about von Eschenbach's appointment here.
Tags: FDA drug biotech eschenbach chief crawford+chief eschenbach+replaces replaces+crawford
Vote for Von Eschenbach Replaces Crawford as FDA Chief:
|
Rating: 7.33 out of 3 vote(s) cast.
|
| RSS |  |
 | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells